Back

The efficacy and safety of the prasugrel, ticagrelor, and clopidogrel dual antiplatelet therapies following an acute coronary syndrome: A systematic review and Bayesian network meta-analysis

2023-08-16 cardiovascular medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundThe dual-antiplatelet therapies (DAPT) of clopidogrel, prasugrel, or ticagrelor in concomitant use with acetylsalicylic acid are the contemporary treatment regimens for acute coronary syndromes (ACS). Systematic comparative effectiveness and safety analyses currently lack clinically meaningful interpretations of the summarized evidence. MethodsWe systematically searched MEDLINE, EMBASE, CENTRAL, and clinicaltrials.gov for randomized controlled trials (RCTs) that reported on either the...

Predicted journal destinations